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Abstract

Problem: The USP General Chapter <800> guidelines protect healthcare workers from
hazardous drugs (HD) and are enforceable by hospital regulatory organizations. Hospitals should
increase their safe handling and administration of these drugs to be compliant and protect their
workers. This quality improvement project aimed to improve nurse compliance with the safe
handling of USP <800> drugs on the medical-surgical microsystem within 16 weeks.
Context: This clinical nurse leader (CNL) quality improvement project was implemented on
two medical-surgical microsystems in a San Francisco Bay Area hospital system.
Interventions: The team conducted passive observational data collection and active observation
in the form of a questionnaire for nursing staff within two weeks.
Measures: The tools focused on USP <800> signage, personal protective equipment (PPE), use
of USP <800> PPE carts, nurse knowledge, comfortability, frequency of HD administration, and
awareness of unit procedures.
Results: 24.8% of patients were on USP <800> medications. Twenty-seven nurses completed
the questionnaire. Key findings included: 7.5% of door signages present, 44% of nurses surveyed
reported always following PPE recommendations, and nurses self-reported high knowledge of
HD. PPE was donned and doffed correctly 97% of the time.
Conclusion: Continued efforts are necessary to increase USP <800> compliance in the
microsystem. Compliance with the safe handling and administration of HDs is essential to
prevent adverse health outcomes in healthcare workers.
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USP<800> Hazardous Drug Safe-Handling in the Medical-Surgical Microsystem:
A CNL Quality Improvement Project
In the United States, more than eight million healthcare workers are at risk from exposure
to hazardous drugs yearly (CDC, 2020). Exposure to hazardous drugs (HDs) can cause them to
develop acute and chronic health conditions. Skin rashes, infertility, spontaneous abortions,
congenital malformations, leukemia, and other cancers have been linked to HDs (CDC, 2020).
Nurses can come into contact with these HDs in their daily routine, for example, during
medication administration or when crushing pills that can aerosolize them. Common routes of
exposure to HDs are inhalation, absorption through the skin, swallowing, or accidental injection
(cdc.gov, 2020). In addition, bodily fluids such as blood, urine, and feces can expose the nurse to
HDs. After 48 hours, most HDs are excreted from the body but some last for seven days
(Polovich, 2017). There are precautions nurses and other healthcare workers can take to protect
themselves. Proper use of personal protective equipment (PPE), routinely wiping surfaces,
proper handling techniques, spill control, and proper disposal are ways healthcare workers can
protect themselves from exposure to HDs (usp.org, 2020).
It is crucial that hospitals implement standards to protect their workers from developing
preventable health conditions so they do not end up as patients themselves. In 2016, the National
Institute for Occupational Safety and Health (NIOSH) created USP General Chapter <800> (GC
USP <800>) to outline the responsibilities of healthcare facilities to protect their workers from
HDs. These guidelines include HD handling, engineering controls, decontamination control
methods, and documentation standards (usp.org, 2020). GC USP<800> is enforced by state
agencies and regulatory organizations like The Joint Commission (TJC) (usp.org, 2020). In
2019, USP <800> temporarily became enforceable but was remanded until a revision of USP
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<797>. Organizations like TJC recognized the scarcity of PPE and other resources during the
Covid-19 pandemic and did not enforce USP <800> guidelines (jointcommission.org, 2020).
Hospitals are working to increase their USP <800> compliance during this interim period. The
location of this quality improvement project is one such hospital system located in the San
Francisco Bay Area.
My project utilized the clinical nurse leader (CNL) role to improve the safe handling and
administration of USP <800> HDs within the medical-surgical unit. The CNL is a nurse who
utilizes skills in quality improvement to implement evidence-based practice in the healthcare
microsystem (Harris et al., 2018).
Problem Description
The problem this quality improvement project addressed was to increase USP <800>
compliance in the safe handling and administration of two medical-surgical units (med-surg) in a
San Francisco Bay Area hospital system. Our team comprises master's nursing students and the
USP <800> Committee from the hospital. While the oncology unit had the greatest incidence of
administering USP <800> drugs, nurses on that unit had more training and resources in handling
HDs. Therefore, the hospital committee chose the second-highest two units that administer HDs
as target microsystems to increase HD protocol compliance. The hospital decided to study and
improve the USP <800> compliance on non-oncology floors, where less HD training and
resources were available. The two units selected were an endocrine-renal medical surgical unit
(med-surg A) and a post-operative medical surgical unit (med-surg B). The quality improvement
(QI) aim is to assess the units' current USP <800> safe handling and administration practices and
increase PPE compliance. During this project, we conducted a literature review, assessed the
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microsystem, implemented our intervention in a plan-do-study-act cycle, analyzed data, and
presented recommendations to the hospital's USP <800> committee.
Available Knowledge
PICOT Question
The PICOT question used to focus the literature review was: Among hospital staff who
administer USP <800> HDs (P), does active and passive observation (I) increase USP <800>
safe handling compliance (O) in one month (T), compared with only passive observation (C)?
The literature review was conducted using the Cumulative Index to Nursing and Allied Health
(CINAHL), PubMed, and Google Scholar. Keywords for the search included: USP<800>,
hazardous drug administration, hazardous drugs, and NIOSH. Ten articles were selected for
further review using the John Hopkins Literature Review Tool (see Appendix A). The studies
were grouped into three categories based on their themes related to HDs. The category themes
were factors influencing HD administration and exposure, the scope of the problem, and studies
that aimed to reduce HD exposure.
Literature Review
The majority literature focused on factors influencing HD administration and exposure.
Five studies were selected based on focusing on factors that apply to the setting, processes, and
equipment similar to our microsystem. All four studies found PPE availability, patient load, and
workplace safety climate significant factors contributing to nurses not wearing appropriate PPE
while administering HDs. Polovich and Clark 2012, in a cross-sectional mixed-method study,
found nurses' perception of risk to be a key factor. He et al., 2017, surveyed 250 oncology nurses
across the US and found that 90% of nurses only wore one pair of gloves during chemotherapy
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administration. Participation of nurses in nursing practice affairs increased compliance with PPE.
Nurses were more compliant with HD safe handling when they demonstrated high knowledge
and self-efficiency while being assigned fewer patients in one survey study by Callahan et al.
(2016).
A non-experimental level three study was selected for its data on training. The study
found that nurses better adhered to policy when the employer provided: engineering control,
adequate PPE, training, and enough time to use PPE. It also stated that healthcare workers should
be trained and consistently strive to follow safe handling procedures while reporting safety
concerns (McDiarmid & Codon, 2005). Based on these studies, our project should consider the
availability of PPE, the workload relating to time on the unit, and the education of the staff on
the safe handling of PPE.
Three studies were selected that discussed exposure to HD knowledge. The studies were
chosen because they discussed aspects of HD handling not looked at in other studies and filled a
gap in knowledge. Colvin et al. compared nurses' perception of actions to observing their actual
safe handling of HDs. The researchers found nurses under-reported double gloving, gowning,
and properly discarding HDs. However, they overestimated gloving and protecting work surfaces
from HD contamination (2016). In our project, we should consider nursing accuracy in survey
reporting of actions and use a combination of observation and survey data. Hon et al., 2014,
conducted a quasi-experimental study across six hospitals and swabbed worker hands for HDs.
The results showed that the most significant HD load was not on workers who administered
medication but on other staff: volunteers, oncologists, nurse aides, dieticians, and unit clerks.
This indicates that our project should not be limited to nurses but include non-nursing staff. The
last study in this section used a national survey to assess behaviors that expose healthcare
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workers to HDs. Boiano et al. found that workers were exposed when 42% of workers failed to
wear the proper gown PPE. The following caused 12% of those surveyed to be exposed:
pharmacy contact, contaminated clothing, pill leak during medication administration, and failure
to wear chemotherapy gloves. Only 4% of those surveyed reported not wearing gloves and being
exposed, believing skin exposure to be minimal in HD administration (Boiano et al., 2014). This
study shows that while most healthcare workers are knowledgeable about proper PPE, they do
not always comply. Our project should consider barriers to different types of PPE.
The highest-level studies were conducted on interventions to reduce HD exposure. Three
studies were selected based on their interventions and similarities to our microsystem. The first
study is a randomized controlled study with a large sample size that compared nurses who
received one hour of education in the safe handling of HD with quarterly email reminders to a
group that received an additional three videos on PPE and spills. While the participants rated the
training highly, the extra training yielded no significant difference in PPE usage or perceived
barriers (Friese et al., 2019). This indicates that education alone is not enough to change HD
compliance. The second study is a level I systematic review. It found measures that reduced HD
drug exposure included: full PPE use, engineering controls, HD and environment monitoring,
HD identification, and an education and training program for workers (Crickman & Finnell,
2016). This indicates that the microsystem should be set up to provide easy identification of
HDs, PPE, education, and support staff to protect themselves. The final study is only a smallscale quality improvement project but was selected because it successfully increased PPE
compliance in a microsystem similar to the one in this project. The Diana-Farber Cancer institute
implemented a QI project to improve PPE compliance. Initial rates were 30% and by the end of
the project were 90% in one year. The hospital conducted mandatory education initially, then
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added monthly audits with staff feedback to increase staff participation in the change. They used
observation tools and real-time feedback on PPE and included active demonstrations, skill days,
and prizes for compliance (Hennessy & Dynan, 2014). This project shows that a successful QI
initiative actively involves staff. Our microsystem should consider more hands-on approaches
than only online education modules.
This literature review indicates that active and passive observation may increase safe
handling compliance compared to passive observation. However, more than one month may be
needed to see a change in compliance. The research shows that the microsystem's annual
education modules are insufficient to increase compliance. The adequate PPE and active
involvement of staff are essential to instigate change. Active observation involving staff would
provide the needed push to increase the safe handling and administration of HDs if there is
adequate time to implement safety measures.
Rationale
The framework for this project’s implementation combines the Eight Step Change Model
and the Plan-Do-Study-Act Cycle (PDSA). This QI project fits into the larger hospital initiative
to comply with the USP <800> standard. The Eight Step model mirrors the overarching hospital
plan, while the PDSA cycle is this project's part that fits into that larger change initiative.
Kotter's Eight Step Change Model
This quality improvement project is based on Kotter's Eight Step Change Model. This
change theory was developed in 1995 by John Kotter (Kotter International, 2022). The reason for
using this change model is that the steps for change match more closely the needs of the hospital
environment. The literature review showed that successful changes in HD compliance occurred
over time, with staff participation, and had multiple steps. The first step of his change model is to
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create urgency (Kotter International, 2022). The urgency is externally controlled by the deadline
of future USP <800> accreditation inspections.
Steps two through five are this QI project's part in the hospital's overarching project to
bring the hospital system fully into UPS <800> compliance. Step two is to form a powerful
coalition (Kotter International, 2022). The hospital created the USP 800 committee of managers,
unit leaders, and nurses. Our CNL team joined the committee during this project. In step three,
create a vision for change, our team wrote a global AIM and specific AIM to focus our project.
Step four is to communicate the vision (Kotter International, 2022). Our team presented our
project proposal to the hospital committee during this step. Simultaneously, the committee
worked with team leaders across their hospital system to set goals for increasing USP 800
compliance. Step five in Kotter's model is to remove obstacles (Kotter International, 2022). The
primary intervention of this project was to identify and propose solutions to obstacles in USP
<800> compliance.
Steps six through eight are fulfilled by the hospital USP <800> coalition in a broader
expansion of this QI project. Step six is to create short-term wins (Kotter International, 2022).
Short-term wins are when goals are met during the project. The first win was when the USP
<800> carts were created as a system and implemented. The second was when the hospital
updated and rolled out its updated USP <800> education training. The win during this QI project
was the identification of system breakdowns in USP <800> on the units. The successive win
after this project will be the hospital implementing the proposed changes from my project. Step
seven is to build on change, and eight is to anchor the changes in the institution's culture (Kotter
International, 2022). Building on this project, the hospital will expand the project to other units
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in their hospital to continue change. Finally, once the hospital's compliance goal is achieved,
they will incorporate the safety changes into their new safety standards.
Plan-Do-Study-Act Cycle
The plan-do-study-act (PDSA) cycle is a four-step QI process used to guide this project's
stages. The PDSA cycle was originally the plan-do-check-act created by Shewhart in 1986 and
modified by Deming, in 1993, to the PDSA cycle (Taylor et al., 2014). The change plan is
created during the "plan" stage (Taylor et al., 2014). During this phase, the QI team was formed,
the proposal was written, the aim statement was drafted, and the tentative schedule was written.
The second phase of a PDSA cycle is "do" when the project is implemented (Taylor et al., 2014).
During this stage, the intervention was carried out. The third stage is "study," when the results
are examined (Taylor et al., 2014). During this phase, data were analyzed and compared to the
aim. Changes are made in the final "act" stage, and the next steps are created (Taylor et al.,
2014). Recommendations for future change were presented with project results to the hospital
USP <800> Committee. Due to the short duration of our project, future actions to improve the
microsystem will be carried out by the hospital's team. Refer to Appendix C for the project's
PDSA cycle.
Specific Project Aim
The specific aim statement of this QI project is to stand as the goal for the length of the
project. We aim to improve nurse compliance with the safe handling of Hazardous Drugs (USP
<800>), on Medical-Surgical floors A and B, within 16 weeks. We expect a 50% increase in the
use of USP <800> carts, PPE, and door and bathroom signs correctly filled out. This increase
will be measured by passive and active observation and questionnaires. Refer to Appendix B for
the entire global aim statement.
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Methods

Context
Microsystem assessment and project organization are essential components of a
successful QI project. This QI project was implemented using a PDSA cycle (Appendix C), and
the project was organized using a Gantt chart (Appendix D). Weekly meetings were set up with
our team of CNLs. Meetings between the hospital USP <800> team and our CNL team occurred
at each new project stage. After defining the AIM statements (Appendix B), we assessed the
microsystem using the five Ps Assessment, SWOT analysis, and case and effect diagram. A costbenefit analysis was included to inform hospital stakeholders. Key stakeholders included: the
USP <800> committee, unit managers, interdisciplinary hospital staff, and the patients.
Five Ps Assessment
Using a five Ps assessment tool, our team identified the microsystem's purpose, patients,
professionals, processes, and patterns to understand the scope of the problem (Wasson et al.,
2003). This was done through microsystem observation, interacting with staff, reviewing the
hospital's current annual education, and meeting with the hospital USP <800> committee.
Purpose. The purpose of the hospital system that encompasses the microsystems our
team assessed included: dedication to their patients and employees, continuous improvement,
and acting as a highly reliable organization that promotes safety. This project improved safety in
the microsystem and decreased health risks to the patients and employees. This mission and
values demonstrate the organization's commitment to keeping its employees safe. This USP
<800> QI project coincides with the organization's values.
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Patients. The patient populations on the unit were mainly alert and oriented but unable to
ambulate independently. Patients averaged older than 55 years of age. On Med-surg A, the
patients had prescriptions for all routes of medications. However, Med-surg B patients were
mainly on oral or injectable drugs. Intravenous HDs are rarely administered. Subcutaneous
heparin injections were the most common USP <800> medication prescribed on both units. An
average of one to two patients were on chemotherapy as outpatients and were admitted to the
unit with USP <800> drugs still in their system, posing a risk to staff.
Professionals. The professionals on the units made up a diverse interdisciplinary team.
Both units have a manager, nurse educator, social worker, nurses, certified nursing assistants,
charge nurse, and unit secretary on the floor. Other healthcare workers that come daily to the
units are respiratory therapists, physical therapists, phlebotomists, janitors, doctors, and nurse
practitioners. Both units had travel nurses and break nurses, but more were seen on Med-surg B.
The hospital employees receive annual online training on USP <800> precautions and PPE.
However, while many know their role in HD handling, they are unaware of how their roles are
connected; this causes a breakdown in communication. The travel nurses and individuals not
generally on the units may be unaware of the USP <800> protocols and inadvertently cause HD
contamination.
Patterns. The patterns in the two microsystems are different relative to the variation in
layout and patient populations. Med-surg A is a rectangular layout with one nursing station on
opposite sides; each nursing station has a medication room. The medication room has a USP
<800> PPE designated cart. PPE not stocked in the cart can be found in the Covid-19 PPE
supply room. Because this unit has a significant number of isolation and Covid-19 patients, there
is adequate PPE available. On med-surg B, the unit comprises three connecting squares with a
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long hallway running the length of the squares. The supply rooms and hallways are narrow, so
there is less room for the USP <800> carts to fit. The carts on this unit were kept in the middle
supply room and were not routinely fully stocked. The nurses on this unit rarely administered an
HD that required more than double gloving. If they had a higher PPE need for the USP <800>
drug, they obtained PPE from the Covid supply shelf rather than designated carts.
Processes. The processes in the microsystems are designed to follow the hospital USP
<800> yearly training procedure, but actual processes deviate from the training. The electronic
health record (EHR) has a banner identifying the USP <800> category of drug the patient is on.
The banner is designed to populate if the patient answers a questionnaire that they take HDs at
home or are on chemotherapy as an outpatient. This is because the patient may still have HDs in
their system. When a patient is given a new order for a USP <800> drug, the nurse should pull a
blank sign from the medication room, circle the category of PPE to wear, and place one sign
each at the bathroom door and room doors. The sign will alert the janitor or other staff who may
come into contact with bodily fluids of what PPE to wear. When PPE is needed, the hospital has
USP <800> carts stocked with PPE and a laminated sheet to identify which PPE to don. The
carts also contain wipes to decontaminate surfaces, a spill kit for pills less than 5 milliliters, and
a pill crusher. The process taught in hospital training is to take the cart into the patient's room to
crush and administer HDs, then immediately wipe the cart to decrease HD contamination across
the unit. During our 5Ps assessment, nurses reported not taking carts into the rooms. They
crushed medications in the medication rooms and acquired PPE from various locations across the
units, not the dedicated carts.
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SWOT Analysis
The SWOT analysis was used to assess the microsystem's strengths, weaknesses,
opportunities, and threats for action (phf.org, 2017). The strengths of the microsystem were the
tools provided on the unit. There were USP <800> HD carts with PPE on each unit, the computer
system had warning banners for staff to identify HDs, and the staff received yearly HD online
training. Weaknesses of the unit were based on a breakdown in ownership of processes and
communication. Some staff did not use the carts, and one was designated to restock the USP
<800> PPE. The computer HD warning banner PPE identification link was broken. Threats to
the microsystem were the lack of maintenance and the replacement of carts and PPE.
Opportunities for improvement lay in incorporating USP <800> guidelines into existing
processes. The person who stocks the unit PPE can be assigned to stock HD PPE. Door signages
identifying patients on HDs can be incorporated into existing charge nurse rounding. The
microsystem has the existing framework for a successful USP <800> implementation and needs
to integrate HD safe administration into current practices. (See Appendix E).
Cause and Effect Diagram
Causes of unsafe HD administration were analyzed as part of the unit assessment. The
root cause analysis of the microsystem was conducted using a cause-and-effect analysis with the
fishbone diagram tool (see Appendix F). Key findings on the unit were in patient volume,
environment, processes, and materials. The patient volume is roughly 36 per unit, with only one
to three USP <800> carts for HD administration. The environment of unit B was large, but
storage rooms and hallways were too narrow to store the PPE carts. This resulted in nurses
preferring to obtain PPE from supply closets closer to their patient rooms which were viewed as
faster and easier to access. In processes, there was no designated person in charge of the cart or
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signage process, and a need for more communication on cart and signage requirements. Unclear
processes contributed to the lack of adherence to HD protocol.
Intervention
The intervention was created based on evidence-based practice research, hospital policy
and procedures, analysis of the microsystem assessment, and collaboration with the hospital USP
<800> committee. The intervention was a combination of active and passive observation.
The passive observation was collected by CNLs on the unit using an observational data
collection form created for this project (see Appendix G). The data collected focused on the
electronic health record (EHR), patient room USP <800> signage, appropriate PPE usage, and
USP <800> carts.
Active observation in the form of an anonymous formal questionnaire was administered
to nursing staff by the CNLs. The questionnaire was administered "elbow-to-elbow" in person
between the nurse and CNL. It covered the nurses' self-reported knowledge of USP <800> drugs,
comfortability, and frequency of administering HDs, HD carts, HD waste containers, and HD
signage (see Appendix H). These topics were chosen because they are the foundation of the
hospital's yearly USP <800> training. Informal interviews of non-nursing staff were conducted
with nursing assistants, janitorial staff, and pharmacy.
Study of the Intervention
The intervention was implemented over two weeks in person on the units by the CNLs.
This QI project used quantitative and qualitative data collection, with both tools having open and
closed-ended questions, to gain as much information as possible on the current status of USP
<800> practices in the microsystem.
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The observational data collection form tool covered 12 questions (see Appendix G). The
first two questions covered unit metrics. The number of patients on USP <800> medications was
to compare the actual number of HD administered to the nursing perceived number of HDs from
the questionnaire. Questions three and four cover the functioning of the EHR HD banner.
Question five asks if there is correct signage on bathrooms and patient doors. This was included
because without this sign, the non-nursing staff and visitors do not have a way of knowing there
is a risk of HD exposure. Questions six through eight cover correct PPE usage for HD. This was
measured to compare nurses' reporting of PPE from the questionnaire to actual PPE usage. It also
measures whether PPE is selected, donned, and doffed correctly to protect the wearer. Nine to
eleven is an inventory of the unit's USP <800> carts and identification of PPE locations on the
unit. The last question is an open-ended question where interviews with non-nursing staff were
recorded.
The active observation questionnaires were kept short at seven questions to increase the
number of nurses willing to take the questionnaire (see Appendix H). Questions one through six
were qualitative. Most questions were on a Likert scale of zero (none) to ten (high), with a yes or
no answer and a numeric answer. This was to keep it answerable in under two minutes because
of management's concern of "survey fatigue" on the units. The last question was an open-ended
question for improving unit USP <800> procedures.
Measures
The goal of the intervention period was to collect questionnaire data from 75% of
dayshift nurses on the units and capture dayshift observational data. The observational tool for
all categorical variables, except USP <800> carts, was analyzed and compared as percentages.
The data on USP <800> carts was analyzed as averages of PPE. The questionnaire tool data was
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analyzed as mean scores. All quantitative data were analyzed separately by unit, then combined
and analyzed as a whole data set. Finally, qualitative open-ended answers were selected as
representative of themes in answers and compiled as an anonymous staff comments chart.
Ethical Considerations
The American Nurses Association's Code of Ethics (COE) Provision 3 is the foundation
of this QI project (ANA, 2015). The COE provision three states that "the nurse promotes,
advocates for, and protects the rights, health, and safety of the patient" (ANA, 2015). This call to
safety by the COE extends to provision 3.4; nurses are responsible for fostering a culture of
safety (ANA, 2015). Nurses have an ethical obligation to uphold health and safety, which
extends to themselves. Promoting USP <800> safe handling and administration of HD decreases
the risk of adverse health outcomes and increases the safety of the nurses and other staff in the
hospital.
This was a non-research quality improvement project and was not subject to IRB
oversight. This was determined using the University of San Francisco's Change Project Checklist
(see Appendix C). This QI project was conducted with the full approval of the hospital and medsurg units. There were no conflicts of interest in this QI initiative.
Results
This section describes the results of the project intervention tools used to improve nurse
administration and safe handling of HDs. The data was collected using passive observation and
active questionnaire tools (see Appendix I and J).
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Passive Observation Results
The first step of data collection was to identify the number of patients on hazardous drugs
to identify our patient population. The EHR was used to identify USP <800> patients on the
units. 29.1% of Unit A patients were on a USP <800> medication, with only 20.7% on Unit B. A
combined total of 24.8% of patients during the project were on a USP <800> drug (see Appendix
K, Chart 1). A total of 155 patients on USP <800> medications during the QI project, divided by
ten days of data collection, equates to an average of 16 patients per day on USP <800>
medications.
The EHR banner nurses use to identify USP <800> patients malfunctioned 31% of the
time. This malfunction was called a "misfire" and defined as the EHR not identifying a USP
<800> medication. 100% of the time, the banner link did not load the PPE recommendation (see
Appendix K, Chart 2).
The number of USP <800> door and bathroom signs were counted during each data
collection day. A sign was considered correct if it was posted by the patient door or bathroom
and filled out correctly. Across both units combined, only 1.7 % of patients had bathroom
signage, and 7.5% had door signage (see Appendix K, Chart 3).
There were 37 incidents of staff utilizing PPE on the units combined. In addition, 97% of
PPE observed across both units was correctly donned and doffed (see Appendix K, Chart 4). The
majority of PPE required was a double glove for HD oral medication.
USP <800> cart inventory on units A and B was conducted and averaged by two carts on
unit A and three carts on unit B. Data was analyzed in a line graph for trends in data. The USP
<800> carts inventory increased on unit A (see Appendix K, Charts 5). On unit B, it initially
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increased and then averaged the same (see Appendix K, Charts 6). The cart PPE combined
average trends up across time (see Appendix K, Chart 7).
Active Observation Results
The in-person questionnaire data was administered to 27 nurses, 14 from unit A and 13
from unit B. The mean of each question was recorded by unit and as a combined mean (see
Appendix K, Table 1). On a scale of 1-10, nurses rated their knowledge of HDs as 7.15 and
comfortability handling HD as 8.45. They self-reported an estimation of 3.44 occurrences of
administering HD per week. 56% reported knowing where USP <800> carts and waste
receptacles were. On a scale of 1-10, nurses rated HD signage and PPE ease of identification as
8.39. 44% of nurses self-reported always following PPE recommendations, 37% reported
sometimes, 15% most of the time, and 14% never (see Appendix K, Table 1). The staff's writtenin answers to the final open-ended question in the questionnaire were recorded in a figure (see
Appendix K, Figure 1). Topics of these answers included feedback on PPE and signage.
Unintended consequences of our project were an increase in nurse survey fatigue and
reduced time on work-related tasks to participate in our project. A secondary effect of our project
was enhanced awareness of USP <800> procedures on the units. The impact of our QI project on
the organization was to increase stakeholders' awareness of current unit processes and
shortcomings related to USP <800> safe handling and administration and provide proposed
solutions.
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Discussion

Summary
This section will summarize the results from this QI project conducted on med-surg units
A and B. I will discuss key findings, relevance to the specific aim, lessons learned, strengths of
the project, and how the project contributed to increasing compliance and safe handling of USP
<800> HDs.
The key findings of this QI project were that 24.8% of patients across the two
microsystems were on USP <800> medications. The results of this project highlight the
importance and need for compliance with policy and procedures to prevent the accidental
exposure of healthcare workers. However, in the questionnaire data, the nurses estimated only
administering HDs a mean of 3.44 times per week. The nurses may be unaware of which drugs
are HDs, and additional training on identification in the EHR is an educational opportunity. The
presence of door and bathroom signage identifying USP <800> patients and correct PPE was
very low. This puts non-nursing employees at risk for HD exposure and adverse health
outcomes. In the questionnaire portion of our data, we discovered that signage is the only way
for janitorial staff to know what PPE to use to protect themselves. However, in the open-ended
section of the questionnaire, nurses reported using methods other than door signages to identify
HDs and PPE. Therefore, the nurses have a knowledge gap regarding why signage is necessary.
We found no individual responsible for proper signage; nurses only posted signs if they had time.
Most nurses did not know where to obtain blank signs.
Although nurses reported high ease of identifying correct PPE, less than half reported
always using recommended PPE. Therefore, future studies should assess barriers to PPE
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compliance in HD administration. The literature review found time and unit safety culture
significant barriers in other studies. Nurses reported a high level of knowledge and
comfortability with USP <800> medications. Future work in the microsystem should focus on
implementing PPE, signage, and spill clean-up rather than knowledge.
The USP <800> carts were not observed to be utilized as intended during observational
data collection. Unit A preferred collecting PPE and crushing HDs in the medication room using
a closed transfer system rather than taking the cart to the room. Unit B did not utilize the carts for
PPE or pill crushing and instead used the medication room for pill crushing and PPE from the
"Covid Supply Closet" on the unit. We found that there was no individual in charge of stocking
USP <800> supplies on both units. The QI project increased USP <800> awareness and
increased cart inventory during the project.
The QI project's specific aim was to see a 50% increase in the use of USP <800> carts,
PPE, and signage. This goal was not met during our project. PPE usage and signage remained the
same throughout the project. While cart usage did not increase, the cart stocking did increase
during the project. This was likely due to increased awareness of HD PPE.
Lessons from this project's methods were that the combination of active and passive
observation yielded better data collection than either intervention individually. The questionnaire
intervention would have been more effective if administered digitally to more participants.
However, the unit managers were concerned about "survey fatigue" among their staff.
The main strength of this project was the collaboration between the USP <800> hospital
committee and our CNL team. This teamwork led to a further-reaching project than what our QI
team could accomplish alone. Our QI project was part of a larger hospital initiative by the

USP<800> SAFE-HANDLING PROJECT

24

hospital USP <800> committee, which will utilize our data and recommendations to build upon
this project's PDSA cycle to increase HD compliance.
Limitations
A significant limitation in implementing this project was the project's time constraint of fifteen
weeks, which allowed only two weeks for data collection. The sample size for our passive and
active observation was small, with 155 patients on HD and 27 nurses participating in our
questionnaire. During questionnaire administration, nurses could select answers on the screen or
provide answers orally. The oral reported answers may have been biased because of the
proximity of colleagues and supervisors. There is a possibility of self-reporting bias in
respondents indicating an unidentifiable knowledge gap. In addition, donning and doffing were
not observed in hospital guests.
Future Recommendations
Based on our findings, recommendations to improve USP <800> compliance and safe
handling can be broken down into two categories PPE and signage. A workflow diagram of each
process illustrates the breakdowns and recommendation implementation (see Appendix L). In
PPE workflow, barriers are when the EHR PPE banner malfunctions and carts are not stocked
with PPE. Both barriers increase nurses' time to don appropriate PPE (see Appendix L, Diagram
1). Increased time poses a significant barrier to PPE compliance (He et al., 2017). The hospital
IT department should repair the broken PPE banner identification link in the EHR. The Unit
secretary, responsible for unit PPE inventory, can easily include inventorying and restocking
USP <800> PPE on the unit. In Unit B, where there is insufficient room for the carts, the "Covid
Supplies" closet can be designated to include USP <800> supplies since this is where most
supplies are pulled from.
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Lack of signage poses a threat to PPE compliance and safety for non-nursing staff. The
charge nurse can incorporate these signs into the daily rounding by generating a list of patients
on HDs, checking for signage when rounding, and providing the list generated to the janitorial
staff (Appendix L, Diagram 2). A barrier to posting signage is finding the sign to fill out. USP
<800> signs can be laminated and stored in the medication room where other isolation signs are
kept. With correct signage, non-nursing staff and visitors can protect themselves from HD
exposure.
Cost Benefit Analysis
The cost-saving benefits of the project pay for the cost of implementing the recommendations.
During our project, there was an average of 16 patients per day on USP <800> medications and
an average of ten nurses per day administering these medications. PPE costs per patient per day
average $12.45 (Muoio, 2021). This comes to $72,708 per year in PPE. Staffing hours to cover
recommendations total $24,729, and signage costs $84. The total yearly cost of implementing the
project recommendations is $97,521 (see Appendix M, Table 1). However, cost-saving benefits
include saved worker's compensation and indirect and direct costs of chemical exposure from
OSHA 2022 data; the benefits total $587,422 (see Appendix M, Table 2). Therefore,
implementing the recommendations would yield $489,901 in savings per year.
Clinical Nurse Leader Relevance
As CNLs in the microsystem, our team utilized CNL roles, professional values, and
competencies. The CNL participates in QI projects to promote the professional values of quality,
care, safety, and fiscal stewardship at the microsystem level (Harris et al., 2018). The CNL roles
performed during this project were systems analyst, outcomes manager, information manager,
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and advocate. Interprofessional communication, assessment, leadership, and quality
improvement were the CNL competencies demonstrated in our project (Harris et al., 2018).
Conclusion
This CNL lead QI project aimed to increase USP <800> compliance and safe
administration on the medical-surgical microsystem. While this QI project did not succeed in
increasing USP <800> PPE, signage, and cart usage during the intervention, our data and
recommendations will be incorporated by the hospital USP <800> committee to create the
subsequent intervention on the units. The sustainability of this project will necessitate creating
more robust unit communication and process ownership on the units. Our QI intervention has the
potential as a valuable tool for data collection on other microsystems of the hospital. However,
the questionnaire tool should be modified to include an assessment of nurse barriers to change.
Application in different medical settings is possible by tailoring the tools to microsystem-specific
USP <800> protocols. We hope this project encourages future QI projects to increase HD safety
and compliance to protect nurses and other healthcare workers. As new drugs are developed each
year, healthcare workers are exposed to even more USP <800> drugs, and the need for safe
practices will continue to expand.
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Appendix A
Literature Review
PICOT Question: Among hospital staff who administer USP <800> Hazardous Drugs,
does active and passive observation increase USP <800> safe handling compliance in one
month?
Level of Evidence
(Type of Evidence)

Source

Synthesis of Findings

Level I
Randomized
controlled study
(larger sample size)

Friese, C., Yang, J., MendelsohnVictor, K., & McCullagh, M. (2019).
Randomized
controlled trial of an intervention to
improve nurses' hazardous drug
handling. Oncology Nursing Forum,
46(2), 248-256.
https://doi.org/10.1188/19.onf.248256

Control intervention: 1 hr
education module on safe HD
handling, NIOSH
recommendations with quizzes,
quarterly email reminders to
reinforce education. Treatment
intervention: 3 videos on PPE,
requirement to report HD drug
spills, quarterly email on spills.
Results: no significant
differences in PPE use,
knowledge, perceived barriers.
Participants reported high
satisfaction with the study
experience.

Level I
Systematic review

Crickman, R., & Finnell, D. (2016).
Systematic review of control
measures to reduce hazardous drug
exposure for healthcare workers.
Journal of Nursing Care Quality,
31(2), 183-190.
https://doi.org/10.1097/NCQ.000000
0000000155

Measures to reduce HD drug
exposure: engineering controls,
full use of PPE, medical and
environmental monitoring,
Hazard identification,
comprehensive HD control
program including education
and training for healthcare
workers.

Level II
Polovich, M. & Clark, P. (2012).
Cross-sectional
Factors influencing oncology nurses'
mixed method study use of hazardous drug safe-handling
precautions. Oncology Nursing
Forum, 39(3), 299-309.
https://doi.org/10.1188/12.ONF.E299
-E309

Factors affecting RN HD safe
handling: inconvenience, PPE
limited availability, expense of
PPE, patient load, safety
climate, supply of PPE.
Perceived risk is key in PPE
use.

Level II
Cross-sectional

n=252 ONS members survey,
26% report of ambulatory

He, B., Mendelsohn-Victor, K.,
McCullagh, M., & Friese, C. (2017).
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Level II
Quasi-experimental

Personal protective equipment uses
and hazardous drug spills among
ambulatory oncology nurses.
Oncology Nursing Forum, 44(1), 6065.
https://doi.org/10.1188/17.ONF.6065
Callahan, A., Ames, N., Manning,
M., Touchton-Leonard, K., Yang, L.,
& Wallen, G. (2016). Factors
influencing nurses' use of hazardous
drug safe-handling precautions.
Oncology Nursing Forum, 43(3), 42349.
https://doi.org/10.1188/16.onf.4303ap
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nurses report HD spill. 90%
wore only one pair of chemo
gloves. Inc PPE use associated
with: inc nurse participation in
practice affairs, non private
ownership, inc nurse workloads,
fewer barriers to PPE.
Factors influencing safe
handling of HD: Participants
demonstrate high knowledge,
self-efficiency, perceived risk,
and workplace safety climate.
Moderate barriers and conflict
of interest. Nurses exhibit more
HD precautions when assigned
fewer patients.

Level II
Quasi-experimental

Hon, C. Y., Teschke, K., Demers, P.
A., & Venners, S. (2014).
Antineoplastic drug contamination on
the hands of employees working
throughout the hospital medication
system. Annals of Occupational
Hygiene, 58(6), 761-770.
https://doi.org/10.1093/annhyg/meu0
19

Six hospitals: swab the front
and back of worker hands,
analyzed for antineoplastic
drugs. Survey on HD exposure.
Results: greatest load was
nondrug admin roles (volunteer,
oncologist, aides, dietician).
Risk of exposure high in more
roles than expected (unit clerk,
aids, dietician,
shipper/receiver).

Level II
Quasi-experimental
mixed-method
Study

Colvin, C., Karius, D., & Albert, N.
(2016). Nurse adherence to safehandling practices: Observation
versus self-assessment. Clinical
Journal of Oncology Nursing, 20(6),
617- 622.
https://doi.org/10.1188/16.cjon.617622

Comparing objective and
subjective nursing behaviors in
HD handling. Behaviors
occurred with greater frequency
than what nurses perceived and
reported on questionnaires
(double gloving, gowning,
properly discharging chemo).
Two behaviors occurred less
frequency than reported (double
gloving, protecting work
surfaces from contamination)

Level III
Non-experimental

McDiarmid, M., & Condon, M.
(2005). Organizational safety

Adherence to the same admin of
HD requires employers: provide
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study

culture/climate and worker
compliance with hazardous drug
guidelines: Lessons from the
bloodborne pathogen experience.
Journal of Occupational
Environmental Medicine, 47(7),740749.
https://doi.org/10.1097/01.jom.00001
65751.21088.46

engineering controls, PPE, safe
training in admin, time to
adhere to safe practices.
Healthcare workers should:
seek training, consistently
follow facility procedures, and
report safety concerns.

Level IV
National Survey

Boiano, J. Steege, A., & Sweeney, M.
(2014). Adherence to safe handling
guidelines by Health Care workers
who administer antineoplastic drugs.
Journal of Occupational and
Environmental
Hygiene, 11(11),728-740.
https://doi.org/10.1080/15459624.201
4.916809

Activities that increase
exposure risk: failure to wear
proper gown (42%), IV tube
primed (6%), pharmacy (12%),
contaminated clothing taken
home (12%), spill leak during
admin (12%), failure to wear
chemo gloves (12%), lack of
HD awareness (4%). Most
common reason for not wearing
gloves was "skin exposure was
minimal" 4% of respondents
reported skin contact.
Recommended practices are not
always followed.

Level V
Quality
Improvement

Hennessy, K., & Dynan, J. (2014).
Improving compliance with personal
protective equipment use through the
model for improvement and staff
champions. Clinical Journal of
Oncology Nursing, 18(5), 497-500.
https://doi.org/10.1188/14.CJON.497
-500

Dana-Farber Cancer institute,
QI project to improve
compliance. Compliance rates
30-40% initially, conducted
mandatory education sessions to
eliminate awareness as a
barrier, no substantive change
post-intervention. 2nd
continuous test change cycle
using Model for Improvement,
monthly audit and standardized
feedback tool. Interventions:
observation of nurse PPE
compliance, real time feedback,
safe handling awareness
campaign with prizes,
demonstrations new PPE, skills
day for spills competency. End
performance level 90%.
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Appendix D
Global Aim Statement
We aim to improve nurse compliance with the safe handling of Hazardous Drugs (USP <800>)
as outlined in the 2022 Hazardous Drugs (HD) Safe Handling and management Updates
Training on the Medical Surgical floors A and B.
The process begins with an initial assessment of the microsystem, a review of the hospital's
Hazardous Drug (USP <800>) policy and procedures, and an investigation of current and
relevant evidence-based nursing research.
The process ends with implementing recommendations based on the assessment of the
microsystem, John Muir policy and procedures, data collected during the project through
questionnaires and observational data, and feedback from the medical-surgical staff.
By working on this process, we expect increased compliance with safe handling of Hazardous
Drugs (USP <800>), including increased use of USP <800> carts and PPE by 50% and an
increased number of Hazardous Drug (USP <800>) signs correctly filled out. This increase will
be measured by the questionnaires and observation data collection.
It is important to work on this now because:
1. Hazardous Drugs (USP <800>) medications pose a health risk to nurses. Therefore,
nurses should be trained to understand the risks and proper techniques to fully protect
themselves.
2. Not following or meeting current standards of safe handling of Hazardous Drugs (USP
<800>) became an enforceable regulation in 2019.
3. Nurses who become ill from repeated exposure to Hazardous Drugs (USP <800>) will
contribute to the nursing shortage.
4. Adequate PPE is now available following the PPE shortage during the COVID-19
pandemic removing this barrier to comply with Hazardous Drugs (USP <800>)
recommendations.
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PDSA Cycle
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SWOT Analysis
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Fishbone Diagram

40

USP<800> SAFE-HANDLING PROJECT
Appendix I
Observational Data Collection Form
1. Site / Number patients on Unit/ Date Collected
2. Number of Patients on USP <800> Drugs
3. Is there an EPIC banner and MAR USP <800> tab to notify staff of HDs?

4. Explain any discrepancy with EPIC banner or MAR USP <800> tab
5. Number of UPS <800> patients with CORRECT Room door signage
a. a. Room door signage
b. B. Bathroom door signage
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6. Do the nurses wear the correct PPE for HD?
7. Please explain nurse wearing PPE correctly, incorrectly, or other
8. Are the nurses donning/doffing PPE correctly?

9. Location of UPS <800> carts?

10. Cart Inventory: RX crush, gowns, chemo gowns, gloves, goggles, face shield, bleach
wipes, sani-wipes, spill kit, laminated HD drug PPE Chart
11. If missing items from USP <800> cart, please elaborate here:
12. Additional Observations or notable data collected
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Appendix K
Results
Chart 1
Patients on USP <800> Hazardous Medications

Chart 2
EHR Banner Errors

Note:
53 Misfire incidences include:
● 31% of the time, the MAR Banner Did NOT List the Appropriate Medication
● 100 % of the time banner did not load the PPE recommendation

USP<800> SAFE-HANDLING PROJECT
Chart 3
USP <800> Signage

Chart 4
Donning & Doffing PPE

45

USP<800> SAFE-HANDLING PROJECT
Chart 5
Unit A Average Number of PPE Per Cart

Chart 6
Unit B Average Number of PPE Per Cart

Chart 7
Combined Average Number of PPE Per Cart
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Process Maps
Diagram 1
PPE Workflow

Diagram 2
Signage Workflow
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Appendix M
Cost Benefit Analysis
Table 1
Project Costs

Table 2
Project Benefits
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